Literature DB >> 20083910

Inflammation and coagulation.

Marcel Levi1, Tom van der Poll.   

Abstract

In the pathogenesis of sepsis, inflammation and coagulation play a pivotal role. Increasing evidence points to an extensive cross-talk between these two systems, whereby inflammation leads to activation of coagulation, and coagulation also considerably affects inflammatory activity. Molecular pathways that contribute to inflammation-induced activation of coagulation have been precisely identified. Pro-inflammatory cytokines and other mediators are capable of activating the coagulation system and down-regulating important physiologic anticoagulant pathways. Activation of the coagulation system and ensuing thrombin generation is dependent on expression of tissue factor and the simultaneous down-regulation of endothelial-bound anticoagulant mechanisms and endogenous fibrinolysis. Conversely, activated coagulation proteases may affect specific cellular receptors on inflammatory cells and endothelial cells and thereby modulate the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083910     DOI: 10.1097/CCM.0b013e3181c98d21

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  247 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

2.  The role of the E2F1 transcription factor in the innate immune response to systemic LPS.

Authors:  Laura A Warg; Judy L Oakes; Rachel Burton; Amanda J Neidermyer; Holly R Rutledge; Steve Groshong; David A Schwartz; Ivana V Yang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-15       Impact factor: 5.464

3.  Impaired dynamics of clot formation and hypofibrinolysis in severe sepsis are coexisting and strictly related.

Authors:  Mauro Panigada; Francesca Sampietro; Camilla L'Acqua; Lucia Zacchetti; Massimo Boscolo Anzoletti; Rossella Bader; Luciano Gattinoni; Armando D'Angelo
Journal:  Intensive Care Med       Date:  2016-01-27       Impact factor: 17.440

4.  Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.

Authors:  Sebastian Steven; Kerstin Jurk; Maximilian Kopp; Swenja Kröller-Schön; Yuliya Mikhed; Kathrin Schwierczek; Siyer Roohani; Fatemeh Kashani; Matthias Oelze; Thomas Klein; Sergey Tokalov; Sven Danckwardt; Susanne Strand; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Br J Pharmacol       Date:  2016-08-21       Impact factor: 8.739

Review 5.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

6.  Factor XI-deficient mice display reduced inflammation, coagulopathy, and bacterial growth during listeriosis.

Authors:  Deyan Luo; Frank M Szaba; Lawrence W Kummer; Lawrence L Johnson; Erik I Tucker; Andras Gruber; David Gailani; Stephen T Smiley
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

7.  Predictive Ability of Preoperative PT-INR and Postoperative MCP1 for Post-hepatectomy Liver Failure.

Authors:  Sayaka Arisaka; Ryusei Matsuyama; Koki Goto; Yusuke Suwa; Ryutaro Mori; Daisuke Morioka; Masataka Taguri; Itaru Endo
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

8.  Endothelial injury in sepsis.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Intensive Care Med       Date:  2013-08-08       Impact factor: 17.440

Review 9.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 10.  Novel insights into molecular mechanisms of abruption-induced preterm birth.

Authors:  Catalin S Buhimschi; Frederik Schatz; Graciela Krikun; Irina A Buhimschi; Charles J Lockwood
Journal:  Expert Rev Mol Med       Date:  2010-11-01       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.